PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

92 hedge funds and large institutions have $282M invested in Paratek Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+6
Holders Change %
+6.98%
% of All Funds
2.3%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
20
Increased
27
Reduced
23
Closed
14
Calls
$388K
Puts
$1.47M
Net Calls
-$1.09M
Net Calls Change
-$1.53M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
$13.9M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
$3.86M
3
Boston Partners
Boston Partners
Massachusetts
$2.42M
4
NC
Nexthera Capital
New York
$1.54M
5
Vanguard Group
Vanguard Group
Pennsylvania
$10.2M

Top Sellers

1
GAI
General American Investors
New York
$4.05M
2
NI
Numeric Investors
Massachusetts
$0
3
LOAMU
Lombard Odier Asset Management (USA)
New York
$0
4
SM
Sabby Management
Florida
$1.69M
5
CS
Candriam SCA
Luxembourg
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IWM
101
Integrated Wealth Management
California
– -$59K -4,500 Closed
CSS
102
Cubist Systematic Strategies
Connecticut
– -$11K -822 Closed
UBS Group
103
UBS Group
Switzerland
– -$2K -166 Closed
PHK
104
Point72 Hong Kong
Hong Kong
– -$1K -100 Closed
TRCT
105
Tower Research Capital (TRC)
New York
– -$1K -100 Closed
1 2 3 4
5